Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis
Source abstract
Abstract
JQ1, a specific inhibitor of bromodomain-containing protein 4 (BRD4), could have great potential in the treatment of cervical cancer. However, its clinical application is limited by its short plasma half-life and limited antitumor efficacy. In this work, cisplatin (CDDP) was first utilized as the stabilizer and cooperator in the nanosystem (mPEG113-b-P(Glu10-co-Phe10)-CDDP/JQ1, called PGP-CDDP/JQ1) to break through the efficiency limitation of JQ1. The PGP-CDDP/JQ1 had a combination index (CI) of 0.21, exerting a strong cytotoxic synergistic effect. In vivo experiments revealed that PGP-CDDP/JQ1 had a significantly higher tumor inhibition effect (tumor inhibition rate: 85% vs 14%) and plasma stability of JQ1 (area under the curve (AUC0-∞): 335.97 vs 16.88 μg × h/mL) than free JQ1. The mechanism underling the synergism of JQ1 with CDDP in PGP-CDDP/JQ1 was uncovered to be inhibiting Plk1-mutant Trp53 axis. Thus, this study provides an optional method for improving the clinical application of JQ1 in cervical cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Protein Degradation and Inhibitors · Advanced biosensing and bioanalysis techniques · Multiple Myeloma Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130022, PR China
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China
The Department of Pain, The Second Hospital of Jilin University, Changchun 130022, PR China
Funding
Department of Science and Technology of Jilin Province · National Natural Science Foundation of China
References (44)
Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1016/S0140-6736(18)32470-X10.1016/S0140-6736(18)32470-X ↗
3. Cervical Cancer. https://www.who.int/health-topics/cervical-cancer#tab=tab_1 (accessed Mar 3, 2021).
4. 10.1172/JCI7820610.1172/JCI78206 ↗
5. 10.1128/mBio.01446-1610.1128/mBio.01446-16 ↗
6. 10.1016/j.tim.2017.07.00710.1016/j.tim.2017.07.007 ↗
7. 10.1002/ijc.3198610.1002/ijc.31986 ↗
8. 10.1038/nature0950410.1038/nature09504 ↗
9. 10.1080/15592294.2020.174175710.1080/15592294.2020.1741757 ↗
10. 10.1159/00047240710.1159/000472407 ↗
11. 10.1016/j.ejca.2019.11.01710.1016/j.ejca.2019.11.017 ↗
12. 10.1002/jcp.2941510.1002/jcp.29415 ↗
13. 10.1038/s41598-019-46516-x10.1038/s41598-019-46516-x ↗
14. 10.1210/endocr/bqz03410.1210/endocr/bqz034 ↗
15. 10.2147/DDDT.S18097610.2147/DDDT.S180976 ↗
16. 10.1016/j.celrep.2016.06.09110.1016/j.celrep.2016.06.091 ↗
17. 10.1016/j.canlet.2019.11.02710.1016/j.canlet.2019.11.027 ↗
18. 10.1002/tcr.20180007410.1002/tcr.201800074 ↗
19. 10.1016/S2352-3026(15)00247-110.1016/S2352-3026(15)00247-1 ↗
20. 10.1200/JCO.2018.78.229210.1200/JCO.2018.78.2292 ↗
21. 10.1038/s41419-019-2120-110.1038/s41419-019-2120-1 ↗
22. 10.1111/jcmm.1485710.1111/jcmm.14857 ↗
23. 10.2174/156800961766617062310172210.2174/1568009617666170623101722 ↗
24. 10.1016/j.celrep.2017.11.09510.1016/j.celrep.2017.11.095 ↗
25. 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-610.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6 ↗
26. 10.6004/jnccn.2019.000110.6004/jnccn.2019.0001 ↗
27. 10.1016/0065-2571(84)90007-410.1016/0065-2571(84)90007-4 ↗
28. 10.1021/ja107333g10.1021/ja107333g ↗
29. 10.1039/C9BM00002J10.1039/C9BM00002J ↗
30. 10.1021/mp400738710.1021/mp4007387 ↗
31. 10.1039/C2TB00063F10.1039/C2TB00063F ↗
32. 10.1016/j.celrep.2020.10829010.1016/j.celrep.2020.108290 ↗
33. 10.1038/s41419-018-0789-110.1038/s41419-018-0789-1 ↗
34. 10.1093/bioinformatics/btp61210.1093/bioinformatics/btp612 ↗
35. 10.1093/nar/gkm88210.1093/nar/gkm882 ↗
36. 10.1002/ptr.216310.1002/ptr.2163 ↗
37. 10.1002/humu.2303510.1002/humu.23035 ↗
38. 10.1007/s00018-017-2575-010.1007/s00018-017-2575-0 ↗
39. 10.1038/s41418-018-0246-910.1038/s41418-018-0246-9 ↗
40. 10.1038/ncb176710.1038/ncb1767 ↗
41. 10.1158/0008-5472.CAN-16-137810.1158/0008-5472.CAN-16-1378 ↗
42. 10.1002/1878-0261.1247710.1002/1878-0261.12477 ↗
43. Takeshita T. · Am. J. Transl Res. · 2019 · 11 · 6507
44. 10.1186/s40169-015-0080-310.1186/s40169-015-0080-3 ↗